Citius Oncology, Inc. CTOR Granted (in shares)
Granted (in shares) at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.
The official record: Citius Oncology, Inc.’s 10-K, filed December 23, 2025, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s granted (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s granted (in shares)?
- Citius Oncology, Inc. (CTOR) reported granted (in shares) of 11.6M in Q3 2025.
- What does granted (in shares) mean?
- The total volume of equity-based awards granted to employees, directors, or consultants during the period. This reflects the company's strategy for talent retention and incentive alignment through equity dilution.